A metal-organic framework-based immunomodulatory nanoplatform for anti-atherosclerosis treatment
出版年份 2023 全文链接
标题
A metal-organic framework-based immunomodulatory nanoplatform for anti-atherosclerosis treatment
作者
关键词
-
出版物
JOURNAL OF CONTROLLED RELEASE
Volume 354, Issue -, Pages 615-625
出版商
Elsevier BV
发表日期
2023-01-24
DOI
10.1016/j.jconrel.2023.01.024
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Regulation of the macrophage-related inflammatory microenvironment for atherosclerosis treatment and angiogenesis via anti-cytokine agents
- (2022) Hongji Pu et al. Nano Research
- A multimodal Metal-Organic framework based on unsaturated metal site for enhancing antitumor cytotoxicity through Chemo-Photodynamic therapy
- (2022) Qiongjie Ding et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Virtual Transcriptomics
- (2021) Andrew J. Buckler et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The changing landscape of atherosclerosis
- (2021) Peter Libby NATURE
- Targeting inflammation in atherosclerosis — from experimental insights to the clinic
- (2021) Oliver Soehnlein et al. NATURE REVIEWS DRUG DISCOVERY
- Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery
- (2020) Isabel Abánades Lázaro et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
- (2020) John D. Martin et al. Nature Reviews Clinical Oncology
- Metal–Organic Frameworks for Biomedical Applications
- (2020) Jie Yang et al. Small
- Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages
- (2020) Dong Wang et al. CANCER LETTERS
- Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines
- (2020) Cheng Gao et al. Nature Communications
- A multifunctional aminated UiO-67 metal-organic framework for enhancing antitumor cytotoxicity through bimodal drug delivery
- (2020) Weicong Liu et al. CHEMICAL ENGINEERING JOURNAL
- Immunity and Inflammation in Atherosclerosis
- (2019) Dennis Wolf et al. CIRCULATION RESEARCH
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
- (2019) Elizabeth I. Buchbinder et al. Journal for ImmunoTherapy of Cancer
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
- (2019) Emelia J. Benjamin et al. CIRCULATION
- Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis
- (2019) Ying Wang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Immunotherapy for cardiovascular disease
- (2019) Esther Lutgens et al. EUROPEAN HEART JOURNAL
- The role of Interleukin 1 receptor antagonist in mesenchymal stem cell‐based tissue repair and regeneration
- (2019) Carl Randall Harrell et al. BIOFACTORS
- Rapamycin-Loaded Leukosomes Reverse Vascular Inflammation
- (2019) Christian Boada et al. CIRCULATION RESEARCH
- Macrophage polarization in atherosclerosis
- (2019) Sai Yang et al. CLINICA CHIMICA ACTA
- An acute immune response underlies the benefit of cardiac stem-cell therapy
- (2019) Ronald J. Vagnozzi et al. NATURE
- Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis
- (2018) Kathryn J. Moore et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Seasonal variations in cardiovascular disease
- (2017) Simon Stewart et al. Nature Reviews Cardiology
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFκB pathways in autophagy- and p62-dependent manners
- (2017) Jung Hwa Ko et al. Oncotarget
- Nanomaterials derived from metal–organic frameworks
- (2017) Song Dang et al. Nature Reviews Materials
- Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis
- (2016) D. Karunakaran et al. Science Advances
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Mesenchymal Stem Cell-Derived Interleukin 1 Receptor Antagonist Promotes Macrophage Polarization and Inhibits B Cell Differentiation
- (2015) Patricia Luz-Crawford et al. STEM CELLS
- Rapamycin: One Drug, Many Effects
- (2014) Jing Li et al. Cell Metabolism
- Interleukin-10 Receptor Signaling in Innate Immune Cells Regulates Mucosal Immune Tolerance and Anti-Inflammatory Macrophage Function
- (2014) Dror S. Shouval et al. IMMUNITY
- Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression
- (2014) Manesh Chittezhath et al. IMMUNITY
- Macrophage phenotypes in atherosclerosis
- (2014) Sophie Colin et al. IMMUNOLOGICAL REVIEWS
- A facile synthesis of UiO-66, UiO-67 and their derivatives
- (2013) Michael J. Katz et al. CHEMICAL COMMUNICATIONS
- Rapamycin unbalances the polarization of human macrophages to M1
- (2013) Alessia Mercalli et al. IMMUNOLOGY
- mTOR is a key modulator of ageing and age-related disease
- (2013) Simon C. Johnson et al. NATURE
- Modulation of macrophage phenotype by cell shape
- (2013) F. Y. McWhorter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
- (2012) Jason Park et al. NATURE MATERIALS
- Macrophages in the Pathogenesis of Atherosclerosis
- (2011) Kathryn J. Moore et al. CELL
- IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets
- (2009) Sven Létourneau et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now